Delivery Order SPE2DB22D2214-SPE2DB24FS4DP
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 45-21 mcg inhaler 12 gm. The contract has a completion date of March 28, 2024 and a ceiling value of $1,293.26. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, that serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Advair HFA 45-21 MCG Inhaler 12GM. The $1,475.93 order has a completion date of February 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside was used for this award. The order is part of Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 115-21 MCG inhalers. The $12,577.37 contract has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $1,042.55 for the supply of Advair HFA 230-21 mcg inhalers. The contract has a period of performance through March 1, 2024 and does not include any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Advair HFA 230-21 MCG inhaler, 12 grams. The contract has a potential value of $3,975.72 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has no major subcontractors listed. This delivery order is part of a larger indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Advair HFA 230-21 mcg inhaler, a specialty pharmaceutical product. The $2,099.79 contract has a completion date of February 14, 2024 and is not associated with any set-aside designations. Amerisourcebergen Drug Corp serves as the prime contractor for this award, which is part of the company's...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 230-21 MCG inhalers valued at $16,227.10. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Advair HFA 230-21 mcg inhalers. The contract has a potential value of $1,356.29 and a performance period ending on January 31, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor on this award, which is not designated as a set-aside contract. This delivery order contract is...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $5,393.88 to Amerisourcebergen Drug Corp, a leading global pharmaceutical distributor, for the provision of Advair HFA 115-21 mcg inhalers. This delivery order, with a period of performance through April 2, 2024, is issued under an indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00 that enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $7,194.78 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of Advair HFA 45-21 MCG inhaler 12GM. The contract has a completion date of February 26, 2024 and does not utilize any set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical with a potential value of up to $999,999,999.00 through December...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB24FS4DPDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of an Advair HFA 115-21 mcg inhaler product. The contract, valued at $3,822.15, has a performance period through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations noted. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 3/28/24 |